Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD

NCT00426998 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Choroidal Neovascularization
Macular Degeneration

Interventions

DRUG: Verteporfin
DRUG: Bevacizumab

Sponsor

Retinal Consultants Medical Group